Concepedia

A. Kevin Raymond

AK

Statistics

Publications

38

Citations

3.1K

H-Index

25

Active since

1983

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Anderson Hospital

The University of Texas Health Science Center at Houston

Sarcoma Oncology Center

Baylor College of Medicine

A. Kevin Raymond is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and bone tumors.

Publications per year

1983–2009

38

Publications

38

Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

Charles D. Blanke, Cathryn Rankin, George D. Demetri et al. · Journal of Clinical Oncology · 2008 · 1.1K citations

, , +13

Pediatric osteosarcoma: therapeutic strategies, results, and prognostic factors derived from a 10-year experience.

Melissa M. Hudson, MARK ROBERT JAFFE, N Jaffe et al. · Journal of Clinical Oncology · 1990 · 189 citations

, , +17

Of mice and men: divergent risks of teriparatide-induced osteosarcoma

Vivek Subbiah, Valdemar Madsen, A. Kevin Raymond et al. · Osteoporosis International · 2009 · 177 citations

, , +14

Long-term survival after aggressive resection of pulmonary metastases among children and adolescents with osteosarcoma

Matthew T. Harting, Martin L. Blakely, Norman Jaffe et al. · Journal of Pediatric Surgery · 2006 · 175 citations

, , +16

Is there a role for surgery in patients with “unresectable” cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate?

Courtney L. Scaife, Kelly K. Hunt, Shreyaskumar Patel et al. · The American Journal of Surgery · 2003 · 138 citations

, , +9

1–5 of 38